Effects of thyroid hormones on liver binding sites for human growth hormone, as studied in the rat. 1979

S Duran-Garcia, and J Gomez-Nieto, and M Fouchereau-Peron, and V F Padron, and M J Obregon, and G Morreale de Escobar, and F Escobar del Rey

Several weeks after thyroidectomy (T), female rats stopped growing, and their pituitary GH content had decreased to less than 2--3% of the values found for age-matched controls (C). The liver membranes of such animals were explored with human GH (hGH). It was found that in the severely hypothyroid T rat, the number, but not the affinity, of the lactogenic binding sites was markedly reduced. Treatment of these rats for 3 weeks with 1.75 micrograms or T4 or 0.5 micrograms T3/100 g body weight/day restored growth, increased pituitary GH content and restored the number of liver lactogenic binding sites were practically to normal. As regards the lactogenic binding sites, similar results were obtained when the severely hypothyroid rats were treated with a much lower T4 dose (0.2 microgram/100 g/day): this dose was clearly growth promoting, and restored to normal both the low circulating GH levels and the pituitary PRL content of the severely hypothyroid rat. The changes in plasma PRL were not clear. The lactogenic binding sites on liver membranes from rats which were both thyroidectomized and hypophysectomized were decreased in number. Treatment with 0.5 microgram T3/100 g/day for 30 days (but not for 12 days) resulted in an increase in the number of lactogenic binding sites, though it did not affect growth or the undetectable plasma GH levels. The effect on the lactogenic binding sites was less marked than in T rats with an intact pituitary. It would appear that minute amounts of thyroid hormones are needed for maintenance of liver lactogenic binding sites; it is possible that this not only occurs through mechanism(s) which involve the pituitary, but also through others which do not. The possible role of these receptors in growth processes is not yet clearly understood.

UI MeSH Term Description Entries
D007016 Hypophysectomy Surgical removal or destruction of the hypophysis, or pituitary gland. (Dorland, 28th ed) Hypophysectomies
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D010903 Pituitary Gland, Anterior The anterior glandular lobe of the pituitary gland, also known as the adenohypophysis. It secretes the ADENOHYPOPHYSEAL HORMONES that regulate vital functions such as GROWTH; METABOLISM; and REPRODUCTION. Adenohypophysis,Anterior Lobe of Pituitary,Anterior Pituitary Gland,Lobus Anterior,Pars Distalis of Pituitary,Adenohypophyses,Anterior Pituitary Glands,Anterior, Lobus,Anteriors, Lobus,Lobus Anteriors,Pituitary Anterior Lobe,Pituitary Glands, Anterior,Pituitary Pars Distalis
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin

Related Publications

S Duran-Garcia, and J Gomez-Nieto, and M Fouchereau-Peron, and V F Padron, and M J Obregon, and G Morreale de Escobar, and F Escobar del Rey
August 1979, Endocrinologia japonica,
S Duran-Garcia, and J Gomez-Nieto, and M Fouchereau-Peron, and V F Padron, and M J Obregon, and G Morreale de Escobar, and F Escobar del Rey
February 1981, Biochemical medicine,
S Duran-Garcia, and J Gomez-Nieto, and M Fouchereau-Peron, and V F Padron, and M J Obregon, and G Morreale de Escobar, and F Escobar del Rey
October 1985, Biochemical and biophysical research communications,
S Duran-Garcia, and J Gomez-Nieto, and M Fouchereau-Peron, and V F Padron, and M J Obregon, and G Morreale de Escobar, and F Escobar del Rey
September 1980, Endocrinologia experimentalis,
S Duran-Garcia, and J Gomez-Nieto, and M Fouchereau-Peron, and V F Padron, and M J Obregon, and G Morreale de Escobar, and F Escobar del Rey
March 1976, Metabolism: clinical and experimental,
S Duran-Garcia, and J Gomez-Nieto, and M Fouchereau-Peron, and V F Padron, and M J Obregon, and G Morreale de Escobar, and F Escobar del Rey
January 1982, Molecular and cellular endocrinology,
S Duran-Garcia, and J Gomez-Nieto, and M Fouchereau-Peron, and V F Padron, and M J Obregon, and G Morreale de Escobar, and F Escobar del Rey
November 1987, Biochemical and biophysical research communications,
S Duran-Garcia, and J Gomez-Nieto, and M Fouchereau-Peron, and V F Padron, and M J Obregon, and G Morreale de Escobar, and F Escobar del Rey
November 1977, Biochemical and biophysical research communications,
S Duran-Garcia, and J Gomez-Nieto, and M Fouchereau-Peron, and V F Padron, and M J Obregon, and G Morreale de Escobar, and F Escobar del Rey
September 1973, Folia biologica,
S Duran-Garcia, and J Gomez-Nieto, and M Fouchereau-Peron, and V F Padron, and M J Obregon, and G Morreale de Escobar, and F Escobar del Rey
December 1975, Endocrinology,
Copied contents to your clipboard!